International Journal of Molecular Sciences, 2016 · DOI: 10.3390/ijms18010006 · Published: December 26, 2016
Spinal cord injury (SCI) leads to degeneration of locomotor and sensory neurons. Stem cell therapy offers strategies for spinal cord repair, promoting remyelination and axonal elongation. However, optimized protocols and safety assays are needed before clinical application. Tracking stem cells after transplantation is crucial for determining their migration and viability. Cell tracking can be done by labeling cells with molecular probes or reporter genes. Each stem cell tracking modality has its own advantages and disadvantages, in terms of biocompatibility of molecular probes, detection thresholds, safety, and cost-effectiveness.
Stem cell therapies hold significant promise for treating spinal cord injuries and improving patient outcomes.
Further research is needed to optimize stem cell differentiation protocols, improve tracking methods, and ensure safety before widespread clinical application.
Multimodal imaging markers are needed to improve the accuracy of stem cell tracking, enabling a better understanding of cell fate and therapeutic efficacy.